Dubai, United Arab Emirates: Azizi Developments, a leading private developer in the UAE, has rolled out its vaccination programme in coordination with Dubai Health Authority and the Ministry of Health and Prevention in order to support the UAE’s fight against COVID-19. The inoculation drive was held on the 2nd of February 2021, from 10:00 am to 7:00 pm at Azizi’s offices, in the API Auditorium, Sheikh Zayed Road, where a station was set up for employees and their families to get vaccinated conveniently and free of charge. As per the regulations of the medication, two doses are required.

Azizi Developments, which made available the Sinophram vaccine, launched this initiative in line with UAE's plan to vaccinate more than 50 per cent of the country's population by the end of March 2021. The UAE government is all set to distribute and administer vaccine doses against COVID-19 as quickly as possible.

The first dose was administered following an assessment of the employees’ health and the second will be given after a period of between 21 to 28 days.

In his comments, Mr Mirwais Azizi, Founder and Chairman of Azizi Developments, said: “2020 has been an unprecedented and at times challenging year for us all. We, at Azizi Developments, are a family - the well-being of our employees, customers, and the wider society is of paramount importance to us. We have to take initiative and be at the forefront of the vaccine drive to ensure that the UAE's aim of stemming the spread of the virus is achieved in a timely manner.”

He added: “We are working together as a force to aid in the swift recovery of the UAE's property and tourism sectors and encourage our employees, as well as all of our stakeholders, to be part of this drive. We take this moment to thank His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the United Arab Emirates and ruler of the Emirate of Dubai, as well as all of the UAE authorities, for their exemplary efforts in keeping us save and our spirits high in these challenging times.”

Through the immunisation programme, the number of cases, hospitalisations, and deaths will be reduced allowing UAE residents to return to the pre-COVID normal, quickly.

According to an announcement made by the National Emergency Crisis and Disaster Management Authority (NCEMA), the country has achieved a vaccine distribution rate of 25.12 doses per 100 people. The UAE has vaccinated xxx residents against COVID-19 in the last xxx hours. The total doses administered now stand at xxx million.


About Azizi Developments

Azizi Developments is a leading developer based in Dubai, UAE. With thousands of homes successfully delivered to local and international investors and end users of over 100 nationalities, the developer prides itself on its extensive portfolio of modern luxury developments across Dubai’s most sought-after residential destinations, its construction-driven approach, and its commitment to transparency and customer centricity. Azizi’s residential and commercial properties are investor friendly, catering to all lifestyles. The developer makes it its international mission to develop lifestyles and enrich the lives of its residents with a focus on catalysing the vision and development of the markets that it operates in.

Azizi currently has approximately 100 ongoing projects that are to be delivered between 2020 and 2023, and an additional 100+ projects in planning, worth several billion US dollars, that are projected to be delivered between 2023 and 2025. The company has a strong track record and sizeable project pipeline through its extensive land bank and strategic partnerships with Dubai’s key master developers and is instrumental in developing world-class properties in MBR City, Palm Jumeirah, Dubai Healthcare City, Al Furjan, Studio City, Sports City and Downtown Jebel Ali.

For further information about Azizi Developments, please contact:
Tizian H. G. Raab
Head of Public Relations and Communications, CEO’s Office

Send us your press releases to

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.